172 related articles for article (PubMed ID: 38445632)
1. Biological determinants of radioresistance and their remediation in pancreatic cancer.
Seshacharyulu P; Baine MJ; Souchek JJ; Menning M; Kaur S; Yan Y; Ouellette MM; Jain M; Lin C; Batra SK
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):69-92. PubMed ID: 28249796
[TBL] [Abstract][Full Text] [Related]
2. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.
Jain SM; Nagainallur Ravichandran S; Murali Kumar M; Banerjee A; Sun-Zhang A; Zhang H; Pathak R; Sun XF; Pathak S
Cancer Biol Ther; 2024 Dec; 25(1):2317999. PubMed ID: 38445632
[TBL] [Abstract][Full Text] [Related]
3. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
[TBL] [Abstract][Full Text] [Related]
5. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia Modulates Radiosensitivity and Response to Different Radiation Qualities in A549 Non-Small Cell Lung Cancer (NSCLC) Cells.
Nisar H; Labonté FM; Roggan MD; Schmitz C; Chevalier F; Konda B; Diegeler S; Baumstark-Khan C; Hellweg CE
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256084
[TBL] [Abstract][Full Text] [Related]
7. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
[TBL] [Abstract][Full Text] [Related]
8. The Role of Macrophages in the Pathogenesis of Atherosclerosis.
Blagov AV; Markin AM; Bogatyreva AI; Tolstik TV; Sukhorukov VN; Orekhov AN
Cells; 2023 Feb; 12(4):. PubMed ID: 36831189
[TBL] [Abstract][Full Text] [Related]
9. KCNE4 expression is correlated with the pathological characteristics of colorectal cancer patients and associated with the radioresistance of cancer cells.
Tian K; Tao Z; Chen Y; Du J; Chen M; Wang D; Li Z
Pathol Res Pract; 2023 Jan; 241():154234. PubMed ID: 36459833
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic and Radiosensitizing Effects of Folic Acid-Conjugated Gold Nanoparticles and Doxorubicin on Colorectal Cancer Cells.
Heshmatian B; Behrouzkia Z; Mohammadian M; Moradi Z; Mohammadi Z; Zohdi Aghdam R
Adv Pharm Bull; 2022 Aug; 12(4):772-779. PubMed ID: 36415636
[No Abstract] [Full Text] [Related]
11. JNC-1043, a Novel Podophyllotoxin Derivative, Exerts Anticancer Drug and Radiosensitizer Effects in Colorectal Cancer Cells.
Kwon JH; Lee NG; Kang AR; Ahn IH; Choi IY; Song JY; Hwang SG; Um HD; Choi JR; Kim J; Park JK
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296600
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions.
Van de Gucht M; Dufait I; Kerkhove L; Corbet C; de Mey S; Jiang H; Law KL; Gevaert T; Feron O; De Ridder M
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291844
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt/mTOR signaling pathway in cancer stem cells.
Karami Fath M; Ebrahimi M; Nourbakhsh E; Zia Hazara A; Mirzaei A; Shafieyari S; Salehi A; Hoseinzadeh M; Payandeh Z; Barati G
Pathol Res Pract; 2022 Sep; 237():154010. PubMed ID: 35843034
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]